HSBC Holdings
MIRM icon

HSBC Holdings’s Mirum Pharmaceuticals MIRM Stock Holding History

HSBC Holdings’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
+12,031
New +$1.21M ﹤0.01% 1746
2025
Q3 		– Sell
-5,330
Closed -$272K – 2983
2025
Q2 		$272K Sell
5,330
-363
-6% -$16.2K ﹤0.01% 2516
2025
Q1 		$257K Sell
5,693
-811
-12% -$38.2K ﹤0.01% 2472
2024
Q4 		$269K Buy
+6,504
New +$271K ﹤0.01% 2559
2019
Q4 		– Sell
-20,792
Closed -$209K – 3139
2019
Q3 		$209K Buy
+20,792
New +$255K ﹤0.01% 2845

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HSBC Holdings's MIRM Position: Q2 2026 in Review

HSBC Holdings opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 12,031 shares worth $1.46M. The stake represents ﹤0.01% of the portfolio and ranks #1746 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in MIRM as recently as Q2 2025.

HSBC Holdings first reported a position in MIRM in Q3 2019 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • HSBC Holdings held 12,031 shares of Mirum Pharmaceuticals worth $1.46M as of Q2 2026.
  • Mirum Pharmaceuticals was a new HSBC Holdings position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1746 holding.
  • HSBC Holdings first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.